Document Detail


Performance of integrated FDG-PET/contrast-enhanced CT in the staging and restaging of colorectal cancer: comparison with PET and enhanced CT.
MedLine Citation:
PMID:  19200683     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The purpose of this study was to assess the diagnostic value of PET/CT as a one step examination in patients with colorectal cancer. Therefore we proved whether diagnostic PET/CT adds information over PET or contrast-enhanced CT alone for staging or restaging of patients with colorectal cancer. METHODS: Seventy-three patients (46 males and 27 females; age range: 50-81 years; mean age: 67 years) with known colorectal cancer underwent 18F-FDG-PET/CT for staging or restaging. RESULTS: Of the 73 patients 26 patients underwent PET/CT for staging and 47 for restaging. 266 metastases could be detected in 60 patients. Contrast-enhanced PET/CT had a lesion-based sensitivity of 100%, contrast-enhanced CT of 91% and PET of 85%. PET/CT identified 2 lesions as false positive. PET/CT could also reach a patient-based sensitivity of 100%, which was superior to contrast-enhanced CT and PET. CONCLUSION: Our study clearly demonstrated the added value of contrast-enhanced PET/CT in staging and restaging patients with colorectal cancer over CT and PET alone.
Authors:
Albert Dirisamer; Benjamin S Halpern; Daniel Fl?ry; Florian Wolf; Mohsen Beheshti; Marius E Mayerhoefer; Werner Langsteger
Related Documents :
3295983 - Colorectal carcinoma: a radiologic and clinical review.
3474233 - Scintigraphy with gallium-67 citrate in staging of soft-tissue sarcomas of the extremity.
20665903 - Evaluation of the radiation dose in micro-ct with optimization of the scan protocol.
Publication Detail:
Type:  Comparative Study; Evaluation Studies; Journal Article     Date:  2009-02-05
Journal Detail:
Title:  European journal of radiology     Volume:  73     ISSN:  1872-7727     ISO Abbreviation:  Eur J Radiol     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-17     Completed Date:  2010-05-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8106411     Medline TA:  Eur J Radiol     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  324-8     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2008 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Department of Nuclear Medicine, St. Vincent's Hospital, Seilerstaette 4, 4010 Linz, Austria. albert.dirisamer@meduniwien.ac.at
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Colorectal Neoplasms / diagnosis*
Contrast Media
Female
Fluorodeoxyglucose F18 / diagnostic use*
Humans
Male
Middle Aged
Neoplasm Recurrence, Local / diagnosis*
Neoplasm Staging
Positron-Emission Tomography / methods*
Radiopharmaceuticals / diagnostic use
Reproducibility of Results
Sensitivity and Specificity
Systems Integration
Tomography, X-Ray Computed / methods*
Chemical
Reg. No./Substance:
0/Contrast Media; 0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Central venous infusion port inserted via high versus low jugular venous approaches: Retrospective c...
Next Document:  Evolution of pathogenicity in the Bacillus cereus group.